Long-term safety and influence on growth in patients receiving sirolimus: a pooled analysisYang‐Yang Wang, Yufen Li, Mengna Zhang et al.|Orphanet Journal of Rare Diseases|2024Cited by 11
Safety Profile of Sirolimus in All Age Groups: A Pooled Analysis of Two 10-Year Cohort Studies Comprising 1738 Patients With Tuberous Sclerosis and/or LymphangioleiomyomatosisLi‐Ping Zou, Yufen Li, Yangyang Wang et al.|SSRN Electronic Journal|2021Cited by 0